Johnson Matthey has confirmed that Catalyst Technologies, following its agreed sale to Honeywell, will be reported as a discontinued operation for 2025/26. In its pre-close update for the half year to 30 September 2025, the group expects strong growth in underlying operating profit, supported by efficiency gains and robust trading in PGM Services...
Johnson Matthey plc appoints Richard Pike as Chief Financial Officer Designate, effective immediately, ensuring a smooth transition before April 2025...
Join Johnson Matthey plc (LON:JMAT) as they host a PGM Services seminar, revealing how PGM Services drive the net zero transition and unlock growth opportunities...
Johnson Matthey Plc (LON:JMAT) has signed an agreement to sell its Medical Device Components business to Montagu Private Equity for US$700 million (£550 million)...
Johnson Matthey has confirmed that Catalyst Technologies, following its agreed sale to Honeywell, will be reported as a discontinued operation for 2025/26. In its pre-close update for the half year to 30 September 2025, the group expects strong growth in underlying operating profit, supported by efficiency gains and robust trading in PGM Services...
Johnson Matthey plc appoints Richard Pike as Chief Financial Officer Designate, effective immediately, ensuring a smooth transition before April 2025...
Join Johnson Matthey plc (LON:JMAT) as they host a PGM Services seminar, revealing how PGM Services drive the net zero transition and unlock growth opportunities...
Johnson Matthey Plc (LON:JMAT) has signed an agreement to sell its Medical Device Components business to Montagu Private Equity for US$700 million (£550 million)...
